Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation "ACT I"

Completed

Phase 3 Results

Summary of Purpose

This study is being conducted to demonstrate the effectiveness of RSD1235 in the conversion of atrial fibrillation to sinus rhythm.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 March 2008.

1 Aug 2003 1 May 2007 1 Nov 2004 1 Nov 2004 1 Mar 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available